Your browser doesn't support javascript.
loading
System Xc- inhibition blocks bone marrow-multiple myeloma exosomal crosstalk, thereby countering bortezomib resistance.
Wang, Fang; Oudaert, Inge; Tu, Chenggong; Maes, Anke; Van der Vreken, Arne; Vlummens, Philip; De Bruyne, Elke; De Veirman, Kim; Wang, Yanmeng; Fan, Rong; Massie, Ann; Vanderkerken, Karin; Shang, Peng; Menu, Eline.
Afiliação
  • Wang F; School of Life Science, Northwestern Polytechnical University, Xi'an, 710072, PR China; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: wangfang1@mail.nwpu.edu.cn.
  • Oudaert I; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Inge.Oudaert@vub.be.
  • Tu C; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Chenggong.Tu@vub.be.
  • Maes A; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Anke.Maes@vub.be.
  • Van der Vreken A; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Arne.Van.Der.Vreken@vub.be.
  • Vlummens P; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium; Department of Clinical Hematology, Universitair Ziekenhuis Gent, Ghent, B-9000, Belgium. Electronic address: Philip.Vlummens@UGent.be.
  • De Bruyne E; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Elke.De.Bruyne@vub.be.
  • De Veirman K; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Kim.De.Veirman@vub.be.
  • Wang Y; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Yanmeng.Wang@vub.be.
  • Fan R; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Rong.Fan@vub.be.
  • Massie A; Neuro-Aging & Viro-Immunotherapy (NAVI), Center for Neurosciences, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Ann.Massie@vub.be.
  • Vanderkerken K; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Karin.Vanderkerken@vub.be.
  • Shang P; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, Shenzhen, 518057, PR China; Key Laboratory for Space Bioscience and Biotechnology, Institute of Special Environment Biophysics, Northwestern Polytechnical University, Xi'an, 710072, PR China. Electronic addres
  • Menu E; Department of Hematology and Immunology, Myeloma Center Brussels, Vrije Universiteit Brussel, Brussels, B-1090, Belgium. Electronic address: Eline.Menu@vub.be.
Cancer Lett ; 535: 215649, 2022 06 01.
Article em En | MEDLINE | ID: mdl-35315341

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exossomos / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Exossomos / Mieloma Múltiplo Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article